Outcomes in patients with spinal muscular atrophy and four or more SMN2 copies treated with onasemnogene abeparvovec: Findings from RESTORE

被引：0
|
作者：
Finkel, R. [1 ]
Benguerba, K. [2 ]
Reid, A. [3 ]
Raju, D. [4 ]
Faulkner, E. [4 ]
LaMarca, N. [4 ]
Servais, L. [5 ]
机构：
[1] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] Novartis Gene Therapies Switzerland GmbH, Rotkreuz, Switzerland
[3] Novartis Global RWE Gene Therapies, London, England
[4] Novartis Gene Therapies Inc, Bannockburn, IL USA
[5] Univ Oxford, Oxford, England
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.073
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.37
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [21] Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?
    Ricci, Martina
    Cicala, Gianpaolo
    Capasso, Anna
    Coratti, Giorgia
    Fiori, Stefania
    Cutrona, Costanza
    D'Amico, Adele
    Sansone, Valeria A.
    Bruno, Claudio
    Messina, Sonia
    Mongini, Tiziana
    Coccia, Michela
    Siciliano, Gabriele
    Pegoraro, Elena
    Masson, Riccardo
    Filosto, Massimiliano
    Comi, Giacomo P.
    Corti, Stefania
    Ronchi, Dario
    Maggi, Lorenzo
    D'Angelo, Maria G.
    Vacchiano, Veria
    Ticci, Chiara
    Ruggiero, Lucia
    Verriello, Lorenzo
    Ricci, Federica S.
    Berardinelli, Angela L.
    Maioli, Maria Antonietta
    Garibaldi, Matteo
    Nigro, Vincenzo
    Previtali, Stefano C.
    Pera, Maria Carmela
    Tizzano, Eduardo
    Pane, Marika
    Tiziano, Francesco Danilo
    Mercuri, Eugenio
    ANNALS OF NEUROLOGY, 2023, 94 (06) : 1126 - 1135
  • [22] Long-term safety of onasemnogene abeparvovec for patients with spinal muscular atrophy: real-world findings from the RESTORE Registry
    Servais, L.
    Alecu, I.
    Lopez-Leon, S.
    Ilic, A.
    Brueckner, A.
    Benguerba, K.
    Reyna, S.
    Dabbous, O.
    Mumneh, N.
    Finkel, R.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [23] Effectiveness and Safety of Onasemnogene Abeparvovec in Older Patients with Spinal Muscular Atrophy (SMA): Real-World Outcomes from the RESTORE Registry
    Servais, Laurent
    De Vivo, Darryl
    Kirschner, Janbernd
    Mercuri, Eugenio
    Muntoni, Francesco
    Tizzano, Eduardo
    Quijano-Roy, Susana
    Saito, Kayoko
    Menier, Melissa
    LaMarca, Nicole
    Anderson, Fred
    Dabbous, Omar
    Finkel, Richard
    NEUROLOGY, 2022, 98 (18)
  • [24] Outcomes of Children Treated With Nusinersen/Onasemnogene Abeparvovec for Pediatric Spinal Muscular Atrophy Type 1
    Chacko, A.
    Sly, P. D.
    Gauld, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [25] Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec
    Retson, Laura
    Tiwari, Nishant
    Vaughn, Jennifer
    Bernes, Saunder
    Adelson, P. David
    Mansfield, Keith
    Libertini, Silvana
    Kuzmiski, Brent
    Alecu, Iulian
    Gabriel, Richard
    Mangum, Ross
    MOLECULAR THERAPY, 2023, 31 (10) : 2991 - 2998
  • [26] Polysomnography findings in children with spinal muscular atrophy after onasemnogene-abeparvovec
    Leon-Astudillo, Carmen
    Wagner, Mary
    Salabarria, Stephanie M.
    Lammers, Jenna
    Berthy, Julie
    Zingariello, Carla D.
    Byrne, Barry J.
    Smith, Barbara K.
    SLEEP MEDICINE, 2023, 101 : 234 - 237
  • [27] Assessment of muscular, respiratory and cardiological function and the number of copies of the SMN2 gene in patients with spinal muscular atrophy (SMA)
    Escobar Cedillo, R.
    Hernandez Hernandez, O.
    Miranda Duarte, A.
    Luna Angulo, A.
    Coral Vazquez, R.
    Ramos Becerril, F.
    Qiuntanar Trejo, L.
    Gomez Diaz, B.
    Suarez Sanchez, R.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S63 - S63
  • [28] Spinal Muscular Atrophy - Is Newborn Screening Too Late for Children with Two SMN2 Copies?
    Schwartz, Oliver
    Koelbel, Heike
    Blaschek, Astrid
    Glaeser, Dieter
    Burggraf, Siegfried
    Roeschinger, Wulf
    Schara, Ulrike
    Mueller-Felber, Wolfgang
    Vill, Katharina
    JOURNAL OF NEUROMUSCULAR DISEASES, 2022, 9 (03) : 389 - 396
  • [29] Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity
    Yosuke Harada
    Retno Sutomo
    Ahmad Hamim Sadewa
    Tomoko Akutsu
    Yasuhiro Takeshima
    Hiroko Wada
    Masafumi Matsuo
    Hisahide Nishio
    Journal of Neurology, 2002, 249 : 1211 - 1219
  • [30] Short-term clinical outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy
    Lee, Seungbok
    Lee, Yun Jeong
    Kong, Juhyun
    Ryu, Hye Won
    Shim, Young Kyu
    Han, Ji Yeon
    Woo, Hyewon
    Kim, Soo Yeon
    Cho, Anna
    Lim, Byung Chan
    Chae, Jong Hee
    BRAIN & DEVELOPMENT, 2022, 44 (04): : 287 - 293
12345